May 17 (Reuters) - Moderna (MRNA.O), opens new tab said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine ...

Moderna said Friday that the European Patent ... rival COVID-19 vaccines. Cambridge-based Moderna has been fighting Pfizer and BioNTech in the courts over the partners’ COVID shot, called ...

The Federal Circuit upheld a ruling that Moderna's COVID-19 vaccine does not infringe Alnylam's mRNA patents related to the SM-102 lipid used in Spikevax.

Who knows, perhaps Genevant, with its billionaire hedge fund owner, or even little Arbutus, might have had a shot at COVID ... to dismiss Moderna's case, insisting that Moderna's patents are ...

Moderna said government ... said Moderna could not defeat case at early stage (Reuters) - Moderna Inc must face a patent infringement lawsuit over its COVID-19 vaccines, a federal judge in ...

3 Summer "Power Patterns" Are About to Trigger (One With 90% Win ... Moderna, claiming it violated a newly obtained patent. The claim is over mRNA technology Moderna used in developing its COVID ...

(Reuters) -Moderna ... patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech. The company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot ...

Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents currently asserted against Pfizer and BioNTech in various European national ...

Moderna said on Friday (May 17) the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.